Stay updated on Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page’s revision label was updated to v3.6.6, signaling a new revision of the study record.
    Difference
    0.0%
    Check dated 2026-09-01T18:25:10.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the page's version. The change does not modify the study details or display content.
    Difference
    0.0%
    Check dated 2026-08-11T14:53:01.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A location entry for Zaporizhzhya, Ukraine, 69600 was added and the Zaporizhzhia, Ukraine, 69600 entry was removed to correct the city spelling in the site listings. The page revision was updated from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-28T05:53:56.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.2 to v3.6.3, indicating a version bump in the page's content management. This change does not modify study data or public study details.
    Difference
    0.0%
    Check dated 2026-07-06T16:37:57.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2 instead of v3.6.0, indicating a newer revision of the page/document.
    Difference
    0.0%
    Check dated 2026-06-29T08:34:59.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    The page gains new helper sections for reading the study record, joining the study, and answering common questions, and the recruitment status is updated to indicate no active enrollment; the revision label is updated to v3.6.0 and the Intervention/Treatment heading formatting is adjusted.
    Difference
    0.3%
    Check dated 2026-06-15T08:18:18.000Z thumbnail image

Stay in the know with updates to Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.